Literature DB >> 16839350

Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions.

E Zorio1, S Navarro, P Medina, A Estellés, A Osa, J Rueda, P Cubillo, J Aznar, F España.   

Abstract

BACKGROUND: Cardiovascular risk factors for myocardial infarction (MI) are less frequent in younger than in older MI survivors. Therefore, the thrombotic component of MI may play a more important role at a young age. As activated protein C (APC) provides systemic anticoagulant and anti-inflammatory protection, a low plasma APC level may be an arterial thrombotic risk factor. AIM: To determine whether there is an association between reduced APC levels and early MI and severe coronary lesions.
METHODS: APC was measured in 231 young MI survivors and 231 controls.
RESULTS: Low APC levels were significantly associated with MI. Compared with the fourth quartile, the odds ratio (OR) for APC values in the first quartile was 3.7 [95% confidence interval (CI) = 2.1-6.4], and 3.2 (1.5-7.0) after adjustment for cardiovascular risk factors. Moreover, each decrease of 0.43 ng mL(-1) (1 SD) in APC increased the OR 1.7 times (1.4-2.2), and 1.5 times (1.2-1.9) after adjustment for cardiovascular risk factors. Low APC levels were also associated with the number of coronary arteries affected and with the severity of coronary lesions (P < 0.001).
CONCLUSIONS: There is a significant association between low circulating APC levels and both early MI and the extent and severity of coronary atherosclerosis, which might be related to the anticoagulant and anti-inflammatory properties of APC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839350     DOI: 10.1111/j.1538-7836.2006.01996.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

Review 1.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

2.  Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.

Authors:  Antje Butschkau; Nana-Maria Wagner; Laura Bierhansl; Berit Genz; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

4.  α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.

Authors:  Laura Martos; Luis Andrés Ramón; Julia Oto; Álvaro Fernández-Pardo; Santiago Bonanad; Ana Rosa Cid; Andras Gruber; John H Griffin; Francisco España; Silvia Navarro; Pilar Medina
Journal:  Thromb Haemost       Date:  2018-02-15       Impact factor: 5.249

5.  Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of Arterial thromboses.

Authors:  Angela Mirela Soare; Constantin Popa
Journal:  J Med Life       Date:  2010 Oct-Dec

Review 6.  Thrombosis and Inflammation-A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C.

Authors:  Shrey Kohli; Khurrum Shahzad; Annukka Jouppila; Harry Holthöfer; Berend Isermann; Riitta Lassila
Journal:  Front Cardiovasc Med       Date:  2022-03-31

7.  The hypercoagulable profile of patients with stent thrombosis.

Authors:  R Loeffen; T C Godschalk; R van Oerle; H M H Spronk; C M Hackeng; J M ten Berg; H ten Cate
Journal:  Heart       Date:  2015-05-21       Impact factor: 5.994

8.  Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.

Authors:  Ferhan S Siddiqi; Andrew Advani
Journal:  Diabetes       Date:  2013-11       Impact factor: 9.461

9.  Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.

Authors:  Hiroshi Deguchi; Silvia Navarro; Amanda B Payne; Darlene J Elias; Nicole F Dowling; Harland D Austin; Francisco España; Pilar Medina; W Craig Hooper; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-23

10.  Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C.

Authors:  Laura Martos; Julia Oto; Álvaro Fernández-Pardo; Emma Plana; María José Solmoirago; Fernando Cana; David Hervás; Santiago Bonanad; Fernando Ferrando; Francisco España; Silvia Navarro; Pilar Medina
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.